drugset / Trial / NCT01216397
Relative Bioavailability of Two Different Batches of a Linagliptin / Metformin Combination Tablet in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The objective of the current study is to investigate the relative bioavailability of two different batches of a 2.5 mg linagliptin / 1000 mg metformin fixed dose combination tablet (FDC).
Timeline
- Start
- 2010-09
- Primary completion
- 2010-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Linagliptin | Small molecule | 2.5 mg | — |
| Subject | Metformin | Small molecule | 1000 mg | — |
Indications
No indication recorded.